Stefano Loizzo Selected Research

cytotoxic necrotizing factor type 1

1/2020	Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.
1/2015	CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice.
8/2014	Enhancement of mitochondrial ATP production by the Escherichia coli cytotoxic necrotizing factor 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Loizzo Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2013
5	Overweight 01/2018 - 01/2006
4	Hyperglycemia 01/2021 - 08/2010
4	Body Weight (Weight, Body) 02/2015 - 11/2006
3	Neuroinflammatory Diseases 05/2020 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 03/2010
2	Neoplasms (Cancer) 01/2020 - 12/2010
2	Glioma (Gliomas) 01/2020 - 05/2018
2	Inflammation (Inflammations) 01/2019 - 01/2014
2	Rett Syndrome (Rett's Disorder) 01/2015 - 08/2014
1	Cushing Syndrome 01/2021
1	Neuroblastoma 05/2020
1	Cognitive Dysfunction 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Hypertensive Retinopathy 01/2019
1	Gliosis 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Parasitic Diseases (Parasitic Disease) 05/2018
1	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Disease Progression 10/2017
1	Anthrax 11/2015
1	Seizures (Absence Seizure) 01/2015
1	Central Nervous System Diseases (CNS Diseases) 01/2014
1	Mesothelioma 01/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2014
1	Atherosclerosis 01/2013
1	Memory Disorders (Memory Loss) 01/2013
1	Type 2 Diabetes Mellitus (MODY) 12/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2010
1	Hypertriglyceridemia 08/2010
1	Sudden Infant Death (SID) 06/2010
1	Stillbirth 06/2010
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 06/2010
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2010
1	Respiratory Insufficiency (Respiratory Failure) 02/2009
1	Tachycardia (Tachyarrhythmias) 09/2007
1	Necrosis 03/2002
1	Pain (Aches) 03/2002

Drug/Important Bio-Agent (IBA)

6	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 11/2006
6	CorticosteroneIBA 01/2021 - 11/2006
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 11/2006
4	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2020 - 01/2013
3	Bacterial ToxinsIBA 05/2020 - 11/2015
3	CytokinesIBA 01/2020 - 03/2002
3	Apolipoprotein E4IBA 01/2020 - 01/2013
3	cytotoxic necrotizing factor type 1IBA 01/2020 - 08/2014
3	Adenosine Triphosphate (ATP)IBA 01/2015 - 01/2013
2	Apolipoproteins E (ApoE)IBA 01/2020 - 10/2017
2	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 11/2010
2	salicylhydroxamic acid (SHAM)IBA 12/2012 - 01/2006
2	Glucose (Dextrose)FDA LinkGeneric 11/2010 - 10/2007
1	Cholinergic Agents (Cholinergics)IBA 11/2021
1	GlucocorticoidsIBA 01/2021
1	AntioxidantsIBA 05/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	Ophthalmic Solutions (Eye Drops)IBA 01/2019
1	avermectinIBA 05/2018
1	artemisinin (artemisinine)IBA 05/2018
1	EndorphinsIBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	Bacterial Proteins (Bacterial Protein)IBA 01/2018
1	Actins (F Actin)IBA 01/2018
1	Apolipoprotein E3IBA 10/2017
1	Tetanus ToxinIBA 11/2015
1	AsbestosIBA 01/2014
1	fluor-edeniteIBA 01/2014
1	Crocidolite Asbestos (Blue Asbestos)IBA 01/2014
1	Amphibole AsbestosIBA 01/2014
1	Amyloid beta-PeptidesIBA 01/2013
1	Pharmaceutical PreparationsIBA 12/2010
1	Messenger RNA (mRNA)IBA 08/2010
1	Hormones (Hormone)IBA 08/2010
1	Tobacco Smoke Pollution (Passive Smoking)IBA 06/2010
1	NAD (NADH)IBA 03/2010
1	Analgesics (Analgesic Drugs)IBA 02/2009
1	Taurine FDA Link 10/2007
1	LipidsIBA 10/2007
1	Insulin (Novolin)FDA Link 10/2007
1	Malondialdehyde (Propanedial)IBA 10/2007
1	ClenbuterolIBA 09/2007
1	OligonucleotidesIBA 11/2006
1	Corticotropin-Releasing HormoneIBA 11/2006
1	Interleukin-2 (IL2)IBA 03/2002
1	Interleukin-10 (Interleukin 10)IBA 03/2002
1	Interferon-gamma (Interferon, gamma)IBA 03/2002
1	SolventsIBA 03/2002
1	Interleukin-4 (Interleukin 4)IBA 03/2002

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2014
1	Topical Administration 01/2019
1	Transcranial Magnetic Stimulation 10/2017